Table 2. Factors associated with a diagnosis of prostate cancer.
| Variable | Univariate | Multivariable | ||
|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Age (continuous) | 1.08 (1.02-1.13) | 0.003 | 1.06 (1.01-1.11) | 0.031 |
| Prostate volume in TRUS (continuous) | 0.99 (0.98-1.00) | 0.669 | - | - |
| Serum PSA (continuous) | 1.31 (1.14-1.50) | 0.001 | 1.28 (1.10-1.47) | 0.001 |
| SUV max (continuous) | 1.10 (0.97-1.24) | 0.129 | - | - |
| Distribution of lesion (focal vs. diffuse) | 3.80 (1.10-14.50) | 0.043 | 5.50 (1.09-27.64) | 0.038 |
OR, odds ratio; CI, confidence interval; TRUS, transrectal ultrasonography; PSA, prostate-specific antigen; SUV, standardized uptake value.